Literature DB >> 31507349

Premalignant and Malignant Perianal Lesions.

Mohammad Ali Abbass1, Michael A Valente1.   

Abstract

Anal cancer is a heterogeneous and rare disease process that accounts for ∼1.5% of all gastrointestinal tract malignancies. The perianal skin plays host to a variety of different premalignant and malignant lesions, all with variable histology, treatment options, and prognosis. Anal cancers in general are notorious for having a delayed or missed diagnosis leading to treatment delays and may have an impact on survival. This delay is in part due to the nonspecific symptomatology and also improper physical examination of the sensitive and anatomically complex perianal region and anal canal. This article examines the various types of perianal cancers and their precursor lesions and will explore treatment options as well as outcomes and prognosis.

Entities:  

Keywords:  Buschke–Löwenstein tumor; anal adenocarcinoma; basal cell carcinoma; extramammary Paget's disease; mycosis fungoides; perianal cancers; squamous cell carcinoma; verrucous carcinoma

Year:  2019        PMID: 31507349      PMCID: PMC6731115          DOI: 10.1055/s-0039-1687835

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  34 in total

Review 1.  Giant condyloma acuminatum of the anorectum: trends in epidemiology and management: report of a case and review of the literature.

Authors:  L J Trombetta; R J Place
Journal:  Dis Colon Rectum       Date:  2001-12       Impact factor: 4.585

2.  Basal cell carcinoma of the perianal region: 20-year experience.

Authors:  C A Paterson; T M Young-Fadok; R R Dozois
Journal:  Dis Colon Rectum       Date:  1999-09       Impact factor: 4.585

3.  Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal.

Authors:  John T Mullen; Miguel A Rodriguez-Bigas; George J Chang; Carlos H Barcenas; Christopher H Crane; John M Skibber; Barry W Feig
Journal:  Ann Surg Oncol       Date:  2006-11-14       Impact factor: 5.344

4.  Long-term outcome of perianal Paget's disease.

Authors:  Martin D McCarter; Stuart H Q Quan; Klaus Busam; Philip P Paty; Douglas Wong; Jose G Guillem
Journal:  Dis Colon Rectum       Date:  2003-05       Impact factor: 4.585

5.  The role of abdominoperineal resection as surgical therapy for anorectal melanoma.

Authors:  Jen Jen Yeh; Jinru Shia; Wen Jen Hwu; Klaus J Busam; Philip B Paty; Jose G Guillem; Daniel G Coit; W Douglas Wong; Martin R Weiser
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

6.  Extramammary Paget's disease of the perianal region.

Authors:  H Tulchinsky; O Zmora; E Brazowski; G Goldman; M Rabau
Journal:  Colorectal Dis       Date:  2004-05       Impact factor: 3.788

Review 7.  Surgical considerations in anal cancer.

Authors:  John Skibber; Miguel A Rodriguez-Bigas; Philip H Gordon
Journal:  Surg Oncol Clin N Am       Date:  2004-04       Impact factor: 3.495

Review 8.  The etiology and epidemiology of anal cancer.

Authors:  Mark Lane Welton; Francis E Sharkey; Morton S Kahlenberg
Journal:  Surg Oncol Clin N Am       Date:  2004-04       Impact factor: 3.495

9.  EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.

Authors:  Rob Glynne-Jones; Helen Meadows; Susan Wan; Simon Gollins; Martin Leslie; Ed Levine; Alec C McDonald; Sun Myint; Les Samuel; David Sebag-Montefiore
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-09       Impact factor: 7.038

Review 10.  Anal neoplasms.

Authors:  Harvey G Moore; José G Guillem
Journal:  Surg Clin North Am       Date:  2002-12       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.